In last trading session, Hancock Jaffe Laboratories, Inc. (NASDAQ:HJLI) saw 1,699,789 shares changing hands with its beta currently measuring 0. Company’s recent per share price level of $0.39 trading at -$0.01 or -2.48% at ring of the bell on the day assigns it a market valuation of $19.41 Million. That closing price of HJLI’s stock is at a discount of -117.95% from its 52-week high price of $0.85 and is indicating a premium of 45.9% from its 52-week low price of $0.211. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 2.66 Million shares which gives us an average trading volume of 11.79 Million if we extend that period to 3-months.
For Hancock Jaffe Laboratories, Inc. (HJLI), analysts’ consensus is at an average recommendation of Buy while assigning it a mean rating of 1. Splitting up the data highlights that, out of 1 analysts covering the stock, none rated the stock as a Sell while none recommended an Overweight rating for the stock. None suggested the stock as a Hold whereas 1 see the stock as a Buy. None analyst(s) advised it as an Underweight. The company is expected to be making an EPS of $0 in the current quarter.
Hancock Jaffe Laboratories, Inc. (NASDAQ:HJLI) trade information
In the face of being in the red today for losing -2.48%, in the last five days HJLI remained trading in the green while hitting it’s week-highest on Wednesday, Oct 14 when the stock touched $0.4049 price level, adding 3.68% to its value on the day. Hancock Jaffe Laboratories, Inc.’s shares saw a change of -29.09% in year-to-date performance and have moved -2.5% in past 5-day. Hancock Jaffe Laboratories, Inc. (NASDAQ:HJLI) showed a performance of -10.26% in past 30-days. Number of shares sold short was 1.25 Million shares which calculate 0.11 days to cover the short interests.
Wall Street analysts have assigned a consensus price target of $2.1 to the stock, which implies a rise of 438.46% to its current value. Analysts have been projecting $2.1 as a low price target for the stock while placing it at a high target of $2.1. It follows that stock’s current price would jump +438.46% in reaching the projected high whereas dropping to the targeted low would mean a loss of 438.46% for stock’s current value.
Hancock Jaffe Laboratories, Inc. (HJLI) estimates and forecasts
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of -39.8% during past 5 years. In 2020, company’s earnings growth rate is likely to be around 72.3% while estimates for its earnings growth in next 5 years are of 0%
Hancock Jaffe Laboratories, Inc. (NASDAQ:HJLI)’s Major holders
Insiders are in possession of 22.44% of company’s total shares while institution are holding 1.27% percent of that, with stock having share float percentage of 1.64%. Investors also watch the number of corporate investors in a company very closely, which is 10 institutions for Hancock Jaffe Laboratories, Inc. that are currently holding shares of the company. Renaissance Technologies, LLC is the top institutional holder at HJLI for having 270.12 Thousand shares of worth $104.24 Thousand. And as of June 29, 2020, it was holding 0.67% of the company’s outstanding shares.
The second largest institutional holder is UBS Group AG, which was holding about 52.7 Thousand shares on June 29, 2020. The number of shares represents firm’s hold over 0.13% of outstanding shares, having a total worth of $20.34 Thousand.